- Analysis
- Barani Krishnan
- 32
Optimax Holdings Berhad, an investment holding company, provides eye specialist services and related products in Malaysia. The company’s specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment of myopia, amblyopia, and squint eyes for kids; eye examination, ortho-k specialist, and orthoptist services for kids; plastic surgery and aesthetic services; lasik surgery service; refractive surgery, consultation and dispensary, oculoplastic surgery, and eye examination services. In addition, the company markets food products; and retails pharmaceuticals, medical, orthopedic goods, perfumery, cosmetic, and toilet articles. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. The company was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.
Metrics to compare | OPTI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPTIPeersSector | |
---|---|---|---|---|
P/E Ratio | 24.2x | 14.8x | −0.6x | |
PEG Ratio | −14.32 | 0.02 | 0.00 | |
Price/Book | 4.6x | 2.3x | 2.6x | |
Price / LTM Sales | 2.5x | 1.9x | 3.1x | |
Upside (Analyst Target) | 45.3% | 28.6% | 48.2% | |
Fair Value Upside | Unlock | 21.9% | 8.0% | Unlock |